Clotet B - Search Results

1

First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.

Fernández-Bastit L, Rodon J, Pradenas E, Marfil S, Trinité B, Parera M, Roca N, Pou A, Cantero G, Lorca-Oró C, Carrillo J, Izquierdo-Useros N, Clotet B, Noguera-Julián M, Blanco J, Vergara-Alert J, Segalés J. Fernández-Bastit L, et al. Among authors: clotet b. Viruses. 2021 Dec 16;13(12):2526. doi: 10.3390/v13122526. Viruses. 2021. PMID: 34960795 Free PMC article.

2

Anti-HIV activity of a novel aminoglycoside-arginine conjugate.

Cabrera C, Gutiérrez A, Barretina J, Blanco J, Litovchick A, Lapidot A, Clotet B, Esté JA. Cabrera C, et al. Among authors: clotet b. Antiviral Res. 2002 Jan;53(1):1-8. doi: 10.1016/s0166-3542(01)00188-7. Antiviral Res. 2002. PMID: 11684311

3

Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.

Blanco J, Barretina J, Gutiérrez A, Armand-Ugón M, Cabrera C, Clotet B, Esté JA. Blanco J, et al. Among authors: clotet b. AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):27-38. doi: 10.1089/088922202753394691. AIDS Res Hum Retroviruses. 2002. PMID: 11804554

4

Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions.

Cabana M, Fernàndez G, Parera M, Clotet B, Martínez MA. Cabana M, et al. Among authors: clotet b. Virology. 2002 Aug 15;300(1):71-8. doi: 10.1006/viro.2002.1520. Virology. 2002. PMID: 12202207 Free article.

5

Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.

Martinez-Picado J, Frost SD, Izquierdo N, Morales-Lopetegi K, Marfil S, Puig T, Cabrera C, Clotet B, Ruiz L. Martinez-Picado J, et al. Among authors: clotet b. J Virol. 2002 Dec;76(23):12344-8. doi: 10.1128/jvi.76.23.12344-12348.2002. J Virol. 2002. PMID: 12414975 Free PMC article.

6

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.

Martínez MA, Gutiérrez A, Armand-Ugón M, Blanco J, Parera M, Gómez J, Clotet B, Esté JA. Martínez MA, et al. Among authors: clotet b. AIDS. 2002 Dec 6;16(18):2385-90. doi: 10.1097/00002030-200212060-00002. AIDS. 2002. PMID: 12461411

7

Reduced fitness of HIV-1 resistant to CXCR4 antagonists.

Armand-Ugón M, Quiñones-Mateu ME, Gutiérez A, Barretina J, Blanco J, Schols D, De Clercq E, Clotet B, Esté JA. Armand-Ugón M, et al. Among authors: clotet b. Antivir Ther. 2003 Feb;8(1):1-8. Antivir Ther. 2003. PMID: 12713058

8

Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.

Barretina J, Blanco J, Armand-Ugón M, Gutiérrez A, Clotet B, Esté JA. Barretina J, et al. Among authors: clotet b. Antivir Ther. 2003 Apr;8(2):155-61. Antivir Ther. 2003. PMID: 12741628

9

Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy.

Parera M, Ibañez A, Clotet B, Martinez MA. Parera M, et al. Among authors: clotet b. J Infect Dis. 2004 Apr 15;189(8):1444-51. doi: 10.1086/382485. Epub 2004 Apr 5. J Infect Dis. 2004. PMID: 15073682

10

R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.

Blanco J, Barretina J, Clotet B, Esté JA. Blanco J, et al. Among authors: clotet b. J Leukoc Biol. 2004 Oct;76(4):804-11. doi: 10.1189/jlb.0204100. Epub 2004 Jul 16. J Leukoc Biol. 2004. PMID: 15258189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,151 results

Search Page

Filters